Jian-hua Zhao

Nanjing, 210009, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications

Circular RNA circASS1 is downregulated in breast cancer cells MDA-MB-231 and suppressed invasion and migration.

Circular RNA circASS1 is downregulated in breast cancer cells MDA-MB-231 and suppressed invasion and migration.

Journal: Epigenomics
Published: January 19, 2019

Circular RNA hsa_circ_0072995 promotes breast cancer cell migration and invasion through sponge for miR-30c-2-3p.

Circular RNA hsa_circ_0072995 promotes breast cancer cell migration and invasion through sponge for miR-30c-2-3p.

Journal: Epigenomics
Published: September 06, 2018

MiR-29a: a potential therapeutic target and promising biomarker in tumors.

MiR-29a: a potential therapeutic target and promising biomarker in tumors.

Journal: Bioscience reports
Published: September 15, 2017

The role of circRNAs in cancers.

The role of circRNAs in cancers.

Journal: Bioscience reports
Published: May 01, 2017

The miR-30 family: Versatile players in breast cancer.

The miR-30 family: Versatile players in breast cancer.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: March 29, 2017

Predictive role of GSTP1-containing exosomes in chemotherapy-resistant breast cancer.

Predictive role of GSTP1-containing exosomes in chemotherapy-resistant breast cancer.

Journal: Gene
Published: February 06, 2017

The role of miRNAs in drug resistance and prognosis of breast cancer formalin-fixed paraffin-embedded tissues.

The role of miRNAs in drug resistance and prognosis of breast cancer formalin-fixed paraffin-embedded tissues.

Journal: Gene
Published: August 17, 2016

Predictive value of glucose transporter-1 and glucose transporter-3 for survival of cancer patients: A meta-analysis.

Predictive value of glucose transporter-1 and glucose transporter-3 for survival of cancer patients: A meta-analysis.

Journal: Oncotarget
Published: July 14, 2016

miR-4443 Participates in the Malignancy of Breast Cancer.

miR-4443 Participates in the Malignancy of Breast Cancer.

Journal: PloS one
Published: April 11, 2016

MiRNAs-mediated cisplatin resistance in breast cancer.

MiRNAs-mediated cisplatin resistance in breast cancer.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: April 03, 2016

miR-222 confers the resistance of breast cancer cells to Adriamycin through suppression of p27(kip1) expression.

miR-222 confers the resistance of breast cancer cells to Adriamycin through suppression of p27(kip1) expression.

Journal: Gene
Published: March 14, 2016

miR-197: A novel biomarker for cancers.

miR-197: A novel biomarker for cancers.

Journal: Gene
Published: March 07, 2016
Showing 1-12 of 29

Last Updated: 09/26/2026